MBOAT2 and endometrial carcinoma: In cases of adrenocortical carcinoma, hepatocellular carcinoma, bladder urothelial carcinoma, endometrial carcinoma, pheochromocytoma and uveal melanoma, high mRNA levels of MBOAT2 can make a poor prognosis more likely [19].